Saturday, July 11, 2026

pharma · Osteoarthritis of Knee

KeyZell

KeyZell clinical programs — 1 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

ES HQ
11 Employees
NMPA registrant Type
Company details
Status
Public
HQ
ES
Employees
11
Programs
1
Drugs
1
Patents
0
Intelligence · Clinical Programs

KeyZell projects

1 ClinicalTrials.gov programs sponsored by KeyZell.

KeyZell has 1 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. AMZ001 Diclofenac gel

    Amzell

    Osteoarthritis of Knee

    phase 3 small molecule completed

    1 trial

Frequently asked questions

How many clinical projects does KeyZell have?

1 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.